Navigation Links
Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children
Date:3/5/2009

ition for months, on average, before a significant flare of dermatitis. Other studies show that using tacrolimus ointment or pimecrolimus cream intermittently at the first signs and symptoms of a flare-up was quite successful. These products may be especially useful for patients who otherwise would have more persistent or frequent recurring eczema."

Barrier Creams and Engineered Emollients

Barrier creams and engineered emollients are newer FDA-approved topical agents that are designed to improve the barrier function of the skin that is compromised in atopic dermatitis. They work by adding lipids, ceramides (natural lipids that act as water regulators) or other agents that help to make damaged skin more "normal." These topical preparations include water-based emulsion with N-palmitoylethanolamide; MAS063ADP, with glycyrrhetinic acid; and ceramide-dominant products.

"Barrier creams and engineered emollients appear very helpful in decreasing symptoms and the need for stronger prescription products, but these medications are fairly new and dermatologists are in the process of assessing their optimal use in atopic dermatitis treatment regimens," said Dr. Eichenfield. "Initial assessments demonstrate that the damaged skin can be improved showing less dryness due to less water loss, less inflammation and less need for more potent anti-inflammatory agents."

Systemic Therapies

For a significant subset of atopic dermatitis patients of all ages, systemic therapy is necessary to control their condition. While systemic therapies for atopic dermatitis pose safety concerns due to their potential side effects, Dr. Eichenfield reported that a few of the newer immunosuppressive agents and newer biologic therapies are being used successfully -- even in children.

"Newer immunosuppressives such as mycophenolate mofetil can be very useful in providing relief for patients wi
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
2. Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
3. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
4. Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder
5. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
6. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
7. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
8. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
9. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
10. Vital Therapies Announces Presentation of ELAD(R) Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meeting
11. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... SAN DIEGO , March 5, 2015 /PRNewswire/ ... company engaged in the development of biosimilar therapeutics ... announced today that its fourth quarter and full ... Monday, March 16, 2015, before the market opens ... management will host a conference call to discuss ...
(Date:3/5/2015)... 2015 Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today it will report fourth ... open on Wednesday, March 25, 2015, followed by ... Eastern. Conference Call & Webcast: ... Domestic: , 800-753-9057International: , 913-981-5571Conference ID: , ...
(Date:3/5/2015)... und TÜBINGEN, Deutschland, 5. März ... Gates Stiftung und das deutsche biopharmazeutische Unternehmen ... 46 Millionen Euro (52 Millionen US-Dollar) in ... Bereich der medizinisch angewandten Messenger-RNA (mRNA). Auf ... Ansätze zur Behandlung von Krankheiten und zum ...
Breaking Medicine Technology:Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4
... N.Y., March 29, 2012 Nano Mask Inc., ... health and wellness related markets, today announced that ... agreement with Tamayz Medical, Inc. (the distributor), a ... Saudi Arabia . Tamayz has agreed to purchase ...
... (Nasdaq: ENDP ) announced today that American Medical Systems, ... the Endo devices operating company in July 2012. While the company ... initiated. Mr. Bihl joined Endo as Group President in ... and Chief Executive Officer of AMS in April 2008. ...
Cached Medicine Technology:Nano Mask Enters Into Five Year $13,000,000 Middle East Distribution Agreement with Tamayz Medical 2Endo Announces Departure of American Medical Systems President 2
(Date:3/6/2015)... The producers of Health Briefs TV ... Washington and vicinity. This is a city which is full ... many outdoor activities. It is also a city where healthcare ... hospitals call the city home and provide care from the ... TV program will be broadcast on CBS KLEW-TV during the ...
(Date:3/6/2015)... IL (PRWEB) March 06, 2015 Fluid ... Boston Marathon qualifier, developed the Fluid Running® ... weeks before the Chicago marathon. She hit upon the ... a group run, and a maximum-resistance, deep water running ... a unique no-impact, deep water running workout that made ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... to be discussed, Ford & Associates Nationwide Legal Services, ... January 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., ... of California. , “In light of a recently ... used Benicar to evaluate and explore the Mayo Clinic's ...
(Date:3/5/2015)... 2015 From Oct. 5-10, Mumbai, India will ... Conference . These dates include the following activities:, ... , October 6: Conference Day 1, ending with ... Conference Day 2, ending with Local Entertainment and Dinner , ... and other Materials Meetings , October 9-10: Textiles ...
(Date:3/5/2015)... digital PCR (dPCR) and qPCR market is expected to reach $3.97 ... , The global digital PCR (dPCR) and qPCR market is estimated ... Although the mature markets such as the U.S., Germany, France and ... market the Asia-Pacific region is expected to grow at the highest ... digital PCR (dPCR) and qPCR market is driven by factors such ...
Breaking Medicine News(10 mins):Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4
... natural family planning that uses two indicators to identify ... as effective as the contraceptive pill for avoiding unplanned ... method (STM) is a form of natural family planning ... of the woman’s fertile phase by measuring her temperature ...
... of America and Europe, anorexia nervosa is said to be ... almost ten years and concluded that people are more prone ... disorder running in the family. ,Dr. Craig ... director of Laureate Psychiatric Hospital in Tulsa divulges that environment ...
... A general practitioner who was accused of prescribing addictive drugs ... General Medical Council. ,Dr. Julien Eden who runs ... of accusations like prescribing sixty sedatives to a teenager with ... of the same drugs later. ,The General Medical ...
... new type of drug that shrinks cancerous tumors by cutting ... most common and deadly form of brain cancer, a pilot ... ,The study marks the first time that Avastin has ... whose chemical name is bevacizumab, currently is used to treat ...
... conducted on 27,000 women adds support to the view that ... of stroke even in healthy women with no history of ... underscore the importance of cholesterol levels as a risk factor ... disease and are otherwise healthy,” said study author Tobias Kurth, ...
... Everyone hopes that one-day stem cell-based regenerative medicine will ... necessary// to decipher the epigenetic signals that give stem ... into different cell types. ,The hype over ... of reprograming cells. By manipulating epigenetic marks, cells can ...
Cached Medicine News:Health News:Family Planning Method is as Effective as the Contraceptive Pill 2Health News:Family Planning Method is as Effective as the Contraceptive Pill 3Health News:Family Planning Method is as Effective as the Contraceptive Pill 4Health News:Cancer Drug can Extend Survival in Patients With Deadly Brain Tumors 2Health News:Cancer Drug can Extend Survival in Patients With Deadly Brain Tumors 3Health News:Epigenetics to Shape Stem Cell Future 2
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: